Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ) and melphalan for melanoma stage III. Results of a multi-centre pilot study
- D. Lienard
- , A. M.M. Eggermont
- , H. Schraffordt Koops
- , B. B.R. Kroon
- , F. Rosenkaimer
- , P. Autier
- , F. J. Lejeune
Research output: Contribution to journal › Article › peer-review
129
Citations
(Scopus)